Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Britain’s decision to exit the European Union isn’t stopping GlaxoSmithKline from deciding to invest more than $350 million at three of its U.K. sites to boost production of new respiratory therapies and biologic medicines. GSK, which employs about 6,000 at nine U.K. manufacturing locations, will expand in Barnard Castle in County Durham, England; Montrose in Angus, Scotland; and Ware in Hertfordshire, England. The company says most of the products will be exported around the world.
This article has been sent to the following recipient: